Noqturina (Desmopressin)

Desmopressin, the active ingredient in Noqturina, is a vasopressin analog presented as a sublingual formulation for sublingual use. It is employed to replace antidiuretic hormone in central diabetes insipidus, to reduce nocturnal enuresis in children and adolescents, and to promote release of coagulation factors in hemophilia A and von Willebrand disease patients. GNH USA supplies Noqturina as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Desmopressin acts on the antidiuretic hormone pathway to manage water balance and coagulation disorders.

- Central diabetes insipidus: reduces excessive urine output by increasing renal water reabsorption. - Nocturnal enuresis: decreases nighttime bedwetting episodes in children and adolescents. - Hemophilia A (bleeding episodes): raises plasma factor VIII levels to help control bleeding. - Von Willebrand disease: enhances release of von Willebrand factor to improve hemostasis.

Desmopressin may cause a range of adverse reactions, from mild to severe, depending on individual susceptibility and concomitant conditions.

Common Side Effects: - Headache: mild to moderate intensity. - Nausea: occasional, often transient. - Abdominal cramps: mild discomfort. - Dry mouth: sensation of reduced salivation. - Facial flushing: transient redness. - Nasal congestion: mild blockage.

Serious or Rare Side Effects: - Hyponatraemia: potentially severe low sodium levels. - Seizures: related to profound hyponatraemia. - Water intoxication: excessive fluid retention. - Allergic reactions: rash, itching, or angioedema. - Thromboembolic events: rare clot formation. - Severe hypotension: marked blood pressure drop.

Before initiating therapy, several safety considerations should be reviewed.

- Monitor serum sodium: check baseline and periodic levels. - Assess fluid intake: advise patients to limit excessive water consumption. - Evaluate renal function: adjust use in impaired kidneys. - Use caution in the elderly: increased susceptibility to hyponatraemia. - Avoid concomitant hyponatraemia‑inducing drugs: such as thiazide diuretics. - Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Desmopressin can interact with other medicines that affect water balance or renal handling of electrolytes.

Major Interactions (Avoid): - Thiazide diuretics: increase risk of hyponatraemia. - NSAIDs: may potentiate water retention. - Other ADH analogues: additive antidiuretic effect.

Moderate Interactions (Monitor Closely): - SSRIs or SNRIs: heightened hyponatraemia risk. - ACE inhibitors or ARBs: may affect renal sodium handling. - Carbamazepine: accelerates desmopressin clearance, reducing efficacy.